
Founded by Bao Fan in 2005, China Renaissance is a leading Chinese financial institution providing investment banking, investment management, and wealth management services. Its principal private equity investment arm, Huaxing Growth Capital, focuses on early- and growth-stage investments in hard technology, artificial intelligence, advanced manufacturing, healthcare, and consumer businesses.
Average disclosed round size is $139.4M (across 15 rounds with reported amounts).
Portfolio
23
Fund Size
$600M
Top Stage
Series C
Last 12 Mo
0
Team
Jiajia, Carol Jiang
Managing Director, Healthcare
Min Chen
Managing Director
Lisa (Lingyun) Yuan
Partner and Investment Committee member
Mark Qiu
CEO & Partner
Michael Du
Partner, Huaxing Growth Capital
Ke Wei
Principal
Ray LIU
Principal Investment
Anqi Wang
Investment Banking Associate
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $100M | Feb 2022 | |
| Series D | $110M | Jan 2022 | |
| SSvolt Energy Technology | Series B | — | Jul 2021 |
| BBlack Lake Technologies | Unknown | $77M | Jan 2021 |
| WWanwudezhi | Series C | $80M | Nov 2020 |
| Series B | $55M | Oct 2020 | |
| Unknown | — | Apr 2020 | |
| Series E | — | Jan 2020 | |
| Series C | $49M | Jan 2020 | |
| Unknown | — | Jan 2020 | |
| Series A | $35M | Jan 2020 | |
| Unknown | — | Jan 2018 | |
| Series C | $100M | Jan 2017 | |
| Series A | $14.3M | Jan 2016 | |
| Series E | $153M | Jan 2016 | |
| UUOKO | Series B | — | Jan 2014 |
| Series A | $100M | — | |
| NNaked Hub | Series C | $200M | — |
| Series C | $308M | — | |
| Series B | $410M | — | |
| 加加特兰 | Series C | — | — |
| XXingbianli | Seed | — | — |
| MMeditrust Health | Series C | — | — |
| Series A | — | — | |
| Series E | $300M | — |
Top Co-Investors
Last updated: 20 October 2026